MedTrace Logo

CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)

NCT01520155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2013-12-23

No results posted yet for this study

Summary

The key of this prospective study is to identify a potentially increased cardiovascular risk in patients with systemic Lupus erythematodes, with and without renal affection. Three groups of patients will be compared.

Conditions

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Joachim R Ehrlich, MD · Frankfurt University Academic Medical Center

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01520155 on ClinicalTrials.gov